Carmen de Mendoza

8.0k total citations
274 papers, 5.1k citations indexed

About

Carmen de Mendoza is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Carmen de Mendoza has authored 274 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Infectious Diseases, 125 papers in Virology and 91 papers in Epidemiology. Recurrent topics in Carmen de Mendoza's work include HIV/AIDS drug development and treatment (139 papers), HIV Research and Treatment (125 papers) and Hepatitis C virus research (86 papers). Carmen de Mendoza is often cited by papers focused on HIV/AIDS drug development and treatment (139 papers), HIV Research and Treatment (125 papers) and Hepatitis C virus research (86 papers). Carmen de Mendoza collaborates with scholars based in Spain, United States and United Kingdom. Carmen de Mendoza's co-authors include Vincent Soriano, Pablo Barreiro, Carmen Garrido, José Vicente Fernández-Montero, Pablo Labarga, Natalia Zahonero, Eva Poveda, Angélica Corral, Ana Treviño and Laura Benítez‐Gutiérrez and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Carmen de Mendoza

266 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carmen de Mendoza Spain	38	3.3k	2.6k	1.7k	1.2k	510	274	5.1k
Françis Barin France	38	3.1k 0.9×	3.6k 1.4×	2.0k 1.2×	829 0.7×	1.5k 3.0×	210	5.9k
Jorge del Romero Spain	34	2.2k 0.7×	1.5k 0.6×	1.6k 1.0×	515 0.4×	397 0.8×	144	3.7k
Phyllis J. Kanki United States	40	3.5k 1.1×	3.6k 1.3×	1.7k 1.0×	307 0.3×	1.2k 2.4×	162	5.9k
Ian Weller United Kingdom	35	2.7k 0.8×	1.8k 0.7×	2.6k 1.5×	1.1k 1.0×	688 1.3×	97	5.7k
Richard Marlink United States	37	4.2k 1.3×	3.6k 1.4×	1.7k 1.0×	297 0.3×	812 1.6×	128	6.0k
Maria E. Taylor United States	11	1.9k 0.6×	2.7k 1.0×	821 0.5×	221 0.2×	1.0k 2.0×	14	3.8k
Anna María Geretti United Kingdom	44	3.5k 1.1×	3.0k 1.1×	2.7k 1.6×	1.4k 1.2×	592 1.2×	195	5.9k
William L. Heyward United States	42	2.1k 0.6×	2.0k 0.7×	2.2k 1.3×	736 0.6×	885 1.7×	85	4.6k
Christophe Pasquier France	37	1.8k 0.5×	1.5k 0.6×	1.7k 1.0×	1.1k 1.0×	374 0.7×	135	3.8k
Suzanne Jurriaans Netherlands	39	3.7k 1.1×	3.5k 1.3×	1.7k 1.0×	815 0.7×	888 1.7×	128	5.6k

Countries citing papers authored by Carmen de Mendoza

Since Specialization

Citations

This map shows the geographic impact of Carmen de Mendoza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen de Mendoza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen de Mendoza more than expected).

Fields of papers citing papers by Carmen de Mendoza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen de Mendoza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen de Mendoza. The network helps show where Carmen de Mendoza may publish in the future.

Co-authorship network of co-authors of Carmen de Mendoza

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen de Mendoza. A scholar is included among the top collaborators of Carmen de Mendoza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen de Mendoza. Carmen de Mendoza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramos, José Manuel, Carmen de Mendoza, Víctor Moreno‐Torres, et al.. (2023). Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain. Journal of Clinical Virology. 167. 105553–105553. 6 indexed citations

Mendoza, Carmen de, Leire Pérez, Ariadna Rando‐Segura, et al.. (2023). HTLV-1-associated myelopathy in Spain. Journal of Clinical Virology. 169. 105619–105619. 8 indexed citations

Mendoza, Carmen de, Estrella Caballero, José Marı́a Eiros Bouza, et al.. (2021). Short Communication: Impact of COVID-19 on Case Reporting for HTLV and HIV-2 in Spain. AIDS Research and Human Retroviruses. 37(8). 610–612. 7 indexed citations

Olson, Ashley, Norbert Bannert, Anders Sönnerborg, et al.. (2017). Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort. AIDS. 32(2). 161–169. 20 indexed citations

Treviño, Ana, Luíz Carlos Júnior Alcântara, Rafael Benito, et al.. (2014). Molecular Epidemiology and Clinical Features of Human T Cell Lymphotropic Virus Type 1 Infection in Spain. AIDS Research and Human Retroviruses. 30(9). 856–862. 9 indexed citations

Arredondo, Miguel, Ana Treviño, Antonio Collado, et al.. (2012). Short Communication: RNASEL Alleles and Susceptibility to Infection by Human Retroviruses and Hepatitis Viruses. AIDS Research and Human Retroviruses. 28(10). 1259–1261. 2 indexed citations

Treviño, Ana, Vincent Soriano, Carmen Rodríguez, et al.. (2010). Changing Rate of Non-B Subtypes and Coinfection with Hepatitis B/C Viruses in Newly Diagnosed HIV Type 1 Individuals in Spain. AIDS Research and Human Retroviruses. 27(6). 633–638. 10 indexed citations

Treviño, Ana, Juan González‐García, Carmen de Mendoza, et al.. (2010). Prevalence of HTLV-1/2 Infections in Spain: A Cross-Sectional Hospital-Based Survey. AIDS Research and Human Retroviruses. 26(8). 861–864. 14 indexed citations

Briz, Verónica, Carmen Garrido, Eva Poveda, et al.. (2009). Raltegravir and Etravirine Are Active against HIV Type 1 Group O. AIDS Research and Human Retroviruses. 25(2). 225–227. 31 indexed citations

10.

Treviño, Ana, Vincent Soriano, Antonio Madejón, et al.. (2009). Short Communication: Transmission of Hepatitis B Viruses with Lamivudine Resistance Mutations in Newly Diagnosed HIV Individuals. AIDS Research and Human Retroviruses. 25(12). 1273–1276. 9 indexed citations

11.

Mendoza, Carmen de, Carmen Garrido, Eva Poveda, et al.. (2009). Changes in Drug Resistance Patterns following the Introduction of HIV Type 1 Non-B Subtypes in Spain. AIDS Research and Human Retroviruses. 25(10). 967–972. 12 indexed citations

12.

Mendoza, Carmen de, et al.. (2008). Resistencia viral y barrera genética de atazanavir. Enfermedades Infecciosas y Microbiología Clínica. 26. 28–33.

13.

Sánchez‐Conde, Matilde, Rosario Palacios, José Sanz, et al.. (2007). Efficacy and Safety of a Once Daily Regimen with Efavirenz, Lamivudine, and Didanosine, with and without Food, as Initial Therapy for HIV Infection: The ELADI Study. AIDS Research and Human Retroviruses. 23(10). 1237–1241. 8 indexed citations

14.

Mendoza, Carmen de, Luz Martı́n-Carbonero, Óscar Gallego, et al.. (2005). Relationship between drug resistance mutations, plasma viremia, and CD4⁺T-cell counts in patients with chronic HIV infection. Journal of Medical Virology. 76(1). 1–6. 7 indexed citations

15.

Rodés, Berta, et al.. (2005). Treatment Response and Drug Resistance in Patients Infected with HIV Type 1 Group O Viruses. AIDS Research and Human Retroviruses. 21(7). 602–607. 12 indexed citations

16.

Chakraborty, Bikram, et al.. (2004). Failure to Detect Human Immunodeficiency Virus Type 1 Superinfection in 28 HIV-Seroconcordant Individuals with High Risk of Reexposure to the Virus. AIDS Research and Human Retroviruses. 20(9). 1026–1031. 25 indexed citations

17.

Mendoza, Carmen de, Anthony de Ronde, Francisco J. Blanco, et al.. (2004). Changes in Mitochondrial DNA Copy Number in Blood Cells from HIV-Infected Patients Undergoing Antiretroviral Therapy. AIDS Research and Human Retroviruses. 20(3). 271–273. 36 indexed citations

18.

Requena, Daniel González de, Óscar Gallego, Carmen de Mendoza, et al.. (2003). Indinavir Plasma Concentrations and Resistance Mutations in Patients Experiencing Early Virological Failure. AIDS Research and Human Retroviruses. 19(6). 457–459. 13 indexed citations

19.

Toro, Carlos, Berta Rodés, Eva Poveda, et al.. (2003). Transmission of HIV Type 1 through Blood Transfusion from an Antibody-Negative/p24 Antigen-Negative Donor. AIDS Research and Human Retroviruses. 19(6). 447–448. 3 indexed citations

20.

Gallego, Óscar, Angélica Corral, Carmen de Mendoza, Berta Rodés, & Vincent Soriano. (2002). Short Communication: Prevalence of G333D/E in Naive and Pretreated HIV-Infected Patients. AIDS Research and Human Retroviruses. 18(12). 857–860. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact